A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents

G. Clement Dobbins; Hideyo Ugai; David T. Curiel; G. Yancey Gillespie

doi:10.1371/journal.pone.0145272

A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents

G. Clement Dobbins
, Hideyo Ugai
, David T. Curiel
, G. Yancey Gillespie

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Studies have demonstrated that oncolytic adenoviruses based on a 24 base pair deletion in the viral E1A gene (D24) may be promising therapeutics for treating a number of cancer types. In order to increase the therapeutic potential of these oncolytic viruses, a novel conditionally replicating adenovirus targeting multiple receptors upregulated on tumors was generated by incorporating an Ad5/3 fiber with a carboxyl terminus RGD ligand. The virus displayed full cytopathic effect in all tumor lines assayed at low titers with improved cytotoxicity over Ad5-RGD D24, Ad5/3 D24 and an HSV oncolytic virus. The virus was then engineered to deliver immunotherapeutic agents such as GM-CSF while maintaining enhanced heterogenic oncolysis.

Original language	English
Article number	e0145272
Journal	PloS one
Volume	10
Issue number	12
DOIs	https://doi.org/10.1371/journal.pone.0145272
State	Published - Dec 1 2015

Access to Document

10.1371/journal.pone.0145272

Cite this

@article{917d24f32da2455299f94867eef10773,

title = "A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents",

abstract = "Studies have demonstrated that oncolytic adenoviruses based on a 24 base pair deletion in the viral E1A gene (D24) may be promising therapeutics for treating a number of cancer types. In order to increase the therapeutic potential of these oncolytic viruses, a novel conditionally replicating adenovirus targeting multiple receptors upregulated on tumors was generated by incorporating an Ad5/3 fiber with a carboxyl terminus RGD ligand. The virus displayed full cytopathic effect in all tumor lines assayed at low titers with improved cytotoxicity over Ad5-RGD D24, Ad5/3 D24 and an HSV oncolytic virus. The virus was then engineered to deliver immunotherapeutic agents such as GM-CSF while maintaining enhanced heterogenic oncolysis.",

author = "Dobbins, \{G. Clement\} and Hideyo Ugai and Curiel, \{David T.\} and Gillespie, \{G. Yancey\}",

note = "Publisher Copyright: {\textcopyright} 2015 Dobbins et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2015",

month = dec,

day = "1",

doi = "10.1371/journal.pone.0145272",

language = "English",

volume = "10",

journal = "PloS one",

issn = "1932-6203",

number = "12",

}

TY - JOUR

T1 - A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents

AU - Dobbins, G. Clement

AU - Ugai, Hideyo

AU - Curiel, David T.

AU - Gillespie, G. Yancey

N1 - Publisher Copyright: © 2015 Dobbins et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Studies have demonstrated that oncolytic adenoviruses based on a 24 base pair deletion in the viral E1A gene (D24) may be promising therapeutics for treating a number of cancer types. In order to increase the therapeutic potential of these oncolytic viruses, a novel conditionally replicating adenovirus targeting multiple receptors upregulated on tumors was generated by incorporating an Ad5/3 fiber with a carboxyl terminus RGD ligand. The virus displayed full cytopathic effect in all tumor lines assayed at low titers with improved cytotoxicity over Ad5-RGD D24, Ad5/3 D24 and an HSV oncolytic virus. The virus was then engineered to deliver immunotherapeutic agents such as GM-CSF while maintaining enhanced heterogenic oncolysis.

AB - Studies have demonstrated that oncolytic adenoviruses based on a 24 base pair deletion in the viral E1A gene (D24) may be promising therapeutics for treating a number of cancer types. In order to increase the therapeutic potential of these oncolytic viruses, a novel conditionally replicating adenovirus targeting multiple receptors upregulated on tumors was generated by incorporating an Ad5/3 fiber with a carboxyl terminus RGD ligand. The virus displayed full cytopathic effect in all tumor lines assayed at low titers with improved cytotoxicity over Ad5-RGD D24, Ad5/3 D24 and an HSV oncolytic virus. The virus was then engineered to deliver immunotherapeutic agents such as GM-CSF while maintaining enhanced heterogenic oncolysis.

UR - https://www.scopus.com/pages/publications/84956943841

U2 - 10.1371/journal.pone.0145272

DO - 10.1371/journal.pone.0145272

M3 - Article

C2 - 26689910

AN - SCOPUS:84956943841

SN - 1932-6203

VL - 10

JO - PloS one

JF - PloS one

IS - 12

M1 - e0145272

ER -

A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents

Abstract

Access to Document

Other files and links

Fingerprint

Cite this